Prognostic value of NT-proBNP monitoring in patients with left ventricular assist devices
NT-proBNP measured at 6 months post-LVAD implantation is a significant predictor of adverse clinical and hemodynamic outcomes at 1 year, supporting its role in risk stratification. Prospective studies are warranted to validate these findings.
Authors
- Larry Barde
- Philippe Rouvière
- Romain Itier
- Pauline Fournier (ORCID: https://orcid.org/0000-0002-4916-5004)
- Philippe Gaudard (ORCID: https://orcid.org/0000-0003-1192-8704)
- Miloud Cherbi (ORCID: https://orcid.org/0009-0004-8952-6283)
- Joaquim Verdaguer
- Aurore Ughetto (ORCID: https://orcid.org/0009-0007-1406-4098)
- Clément Delmas (ORCID: https://orcid.org/0000-0001-9180-9128)
- Adrien Molina
- Etienne Grunenwald
Institutions
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Université de Montpellier (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Hôpital Saint-Jacques (FR)
- Hôpital Arnaud de Villeneuve (FR)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100387
- Citations
- 1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.67